Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Dec;62(12):2179-2187.
doi: 10.1007/s00125-019-05014-5. Epub 2019 Nov 5.

Extracellular vesicles in metabolic disease

Affiliations
Review

Extracellular vesicles in metabolic disease

Naveed Akbar et al. Diabetologia. 2019 Dec.

Abstract

Extracellular vesicles (EVs) are submicron-sized lipid envelopes that are produced and released from a parent cell and can be taken up by a recipient cell. EVs are capable of mediating cellular signalling by carrying nucleic acids, proteins, lipids and cellular metabolites between cells and organs. Metabolic dysfunction is associated with changes in plasma concentrations of EVs as well as alterations in their EV cargo. Since EVs can act as messengers between parent and recipient cells, they could be involved in cell-to-cell and organ-to-organ communication in metabolic diseases. Recent literature has shown that EVs are produced by cells within metabolic tissues, such as adipose tissue, pancreas, muscle and liver. These vesicles have therefore been proposed as a novel intercellular communication mode in systemic metabolic regulation. In this review, we will describe and discuss the current literature that investigates the role of adipose-derived EVs in the regulation of obesity-associated metabolic disease. We will particularly focus on the EV-dependent communication between adipocytes, the vasculature and immune cells in type 2 diabetes.

Keywords: Adipocytes; Diabetes; Diagnostic; Endothelial cells; Exosomes; Extracellular vesicle; Immune cells; Macrophages; Metabolic dysfunction; Platelets; Review; Therapeutic.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The EV landscape at a glance from biogenesis to isolation and characterisation. (a) A schematic representation of the cellular origins of EV sub-populations, their respective classifications based on EV size, and associated markers. Apoptotic bodies are generated by apoptotic blebbing and microvesicles by budding of the plasma membrane. Exosomes are generated from late endosomal MVBs, which fuse with the plasma membrane and release small exosomes. ALIX, ALG-2-interacting protein X; HSP70, heat shock protein 70; TSG101, tumour susceptibility gene 101. (b) The stages of exosome biogenesis. Late endosomes mature into MVBs, which are targeted for degradation or fuse with the plasma membrane to release exosomes. ER, endoplasmic reticulum. (c) The most commonly used techniques for EV isolation from biological fluids: ultracentrifugation, immunoaffinity capture and size-exclusion chromatography. This figure is available as a downloadable slide

References

    1. Srikanthan K, Feyh A, Visweshwar H, Shapiro JI, Sodhi K. Systematic review of metabolic syndrome biomarkers: a panel for early detection, management, and risk stratification in the West Virginian population. Int J Med Sci. 2016;13(1):25–38. doi: 10.7150/ijms.13800. - DOI - PMC - PubMed
    1. Pomatto MAC, Gai C, Deregibus MC, Tetta C, Camussi G. Noncoding RNAs carried by extracellular vesicles in endocrine diseases. Int J Endocrinol. 2018;2018:4302096. doi: 10.1155/2018/4302096. - DOI - PMC - PubMed
    1. O’Neill S, Bohl M, Gregersen S, Hermansen K, O’Driscoll L. Blood-based biomarkers for metabolic syndrome. Trends Endocrinol Metab. 2016;27(6):363–374. doi: 10.1016/j.tem.2016.03.012. - DOI - PubMed
    1. Martínez MC, Andriantsitohaina R. Extracellular vesicles in metabolic syndrome. Circ Res. 2017;120(10):1674–1686. doi: 10.1161/CIRCRESAHA.117.309419. - DOI - PubMed
    1. Lakhter AJ, Sims EK. Minireview: emerging roles for extracellular vesicles in diabetes and related metabolic disorders. Mol Endocrinol. 2015;29(11):1535–1548. doi: 10.1210/me.2015-1206. - DOI - PMC - PubMed

Publication types

MeSH terms